ISSN: 2961 - 4295
Seizure Control During Ramadan Fasting in Epilepsy: A Systematic Review of Clinical Evidence.
Ahmed M. Al-Harby¹², Fatimah Al-salemi¹, Khalid Ngah², Sara Elsahmy¹, Nasser Y. Sofian²
Pages:1-6Aim: This systematic review synthesizes clinical evidence regarding the effects of Ramadan fasting on seizure frequency and control.
Methods: A systematic search of PubMed, Scopus, Web of Science, Embase, and the Cochrane Library was conducted on May 10, 2025, identifying prospective observational studies assessing seizure control during Ramadan fasting. Five studies encompassing 672 patients were included. Quality was appraised using the Newcastle-Ottawa Scale. Due to heterogeneity, findings were narratively synthesized.
Results: The evidence reveals mixed effects of Ramadan fasting on seizure control. Some studies report a significant reduction in focal and myoclonic seizures during and after Ramadan, potentially linked to favorable metabolic adaptations and improved medication adherence. Conversely, other studies observed increased seizure frequency associated with altered antiepileptic drug regimens and sleep disturbances. Medication adherence was variable but critical to seizure outcomes. Quality of life measures showed limited improvement during fasting, reflecting psychosocial stress and physiological challenges.
Conclusion: Ramadan fasting can be safe for well-controlled epilepsy patients with stable medication regimens, but individualized management and close monitoring are essential. Metabolic changes, medication scheduling, and sleep hygiene must be carefully managed to minimize seizure risk. Further large-scale prospective studies are needed to optimize clinical guidelines balancing religious observance with patient safety.
Effect of Preoperative Lugol’s Iodine on Intraoperative Blood Loss in Thyroidectomy in Euthyroid Patients: A Systematic Review and Meta-Analysis
Abdel-Sattar Elshory¹, Fakhry Sanhory², Salma Ismail², Qasem Elotiby¹
Pages:5-11Background: Although Lugol’s iodine is routinely used in hyperthyroid patients before thyroidectomy to reduce gland vascularity, its role in euthyroid patients remains controversial.
Aim: This study aims to evaluate the effectiveness of Lugol’s iodine in reducing intraoperative blood loss in euthyroid patients undergoing thyroidectomy.
Methods: A systematic search of PubMed, Embase, Web of Science, and Scopus was performed up to May 2025. Randomized controlled trials (RCTs) comparing preoperative Lugol’s iodine to placebo or no intervention in euthyroid patients were included. The primary outcome was intraoperative blood loss. Meta-analysis was conducted using a random-effects model, with mean difference (MD) and 95% confidence intervals (CI).
Results: Out of 487 screened records, 3 RCTs with 250 euthyroid patients (125 Lugol’s, 125 control) were included. Lugol’s iodine significantly reduced intraoperative blood loss compared to control (MD: –18.22 mL, 95% CI: –21.53 to –14.92; p < 0.00001). Moderate heterogeneity was observed (I² = 85%). All included studies had moderate-to-high methodological quality. No consistent data on adverse effects were reported.
Conclusion: Preoperative Lugol’s iodine significantly reduces intraoperative blood loss in euthyroid patients undergoing thyroidectomy. While findings support its use as a blood-conserving adjunct, further large-scale trials with standardized protocols are warranted to confirm efficacy and assess safety.
A 50-Year-Old Female with Hypertension Revealing Cushing’s Disease: A Case Report
Khaled Mejahed¹, Abdel-Qader Fakhr¹, Khalid Salman², Salma Emad¹, Ayham F. Reweey²
Pages:1-4Hypertension is a common condition frequently managed in primary care. However, secondary causes such as Cushing’s syndrome may be overlooked, leading to delays in diagnosis and treatment. We present the case of a 50-year-old female with a 5-year history of hypertension who presented for routine medication adjustment. A systematic clinical assessment revealed features suggestive of hypercortisolism. Subsequent biochemical testing confirmed Cushing’s disease, and MRI imaging revealed a pituitary adenoma with associated visual field defects, previously unnoticed by the patient. This case highlights the importance of comprehensive evaluation in hypertensive patients to identify secondary causes and prevent complications.
Impact of gender and age on the risk and clinical characteristics of thyroid cancer: A Retrospective Study at King Abdulaziz University Hospital, Jeddah
Alaa B. Habeebullah¹*, Bandar Mohammed Alharbi², Fuad Abdullah Almalki², Ahmed AbdullahAlmalki², Mohammed Bader Almushageh², Ayman Ruwayjih Almalki², Hamad Abkar Hakami², Meshal Khalaf Allah Almalki
DOI:https://doi.org/10.64039/djms.2025.1102 Pages:9-21Background and Aim: Thyroid cancer incidence has been increasing in Saudi Arabia, with variation by age and sex. This study aimed to evaluate the association of age and sex with clinicopathologic characteristics and outcomes of thyroid cancer.
Methods: We conducted a retrospective medical record review of adult patients with confirmed thyroid cancer diagnosed and/or treated at King Abdulaziz University Hospital, Jeddah, between January 2010 and December 2023. Demographic data, tumour characteristics, treatment, and outcomes were extracted. Statistical analyses were performed using SPSS version 26.
Results: Among 331 patients, papillary carcinoma was the most common histologic subtype. Older age at diagnosis was associated with more advanced stage, larger tumour size, and documented distant metastasis. Male patients were older at diagnosis and had larger tumours, and sex was associated with lymph node metastasis and invasion of adjacent structures.
Conclusion: In this single-center retrospective cohort, age and sex were associated with thyroid cancer characteristics and selected outcomes. These findings support considering age and sex when interpreting disease extent and planning follow-up, while recognizing the limitations of retrospective observational data.
Mapping the Burden of Restless Legs Syndrome across Saudi Arabia: A Systematic Review and Meta-analysis
Hyder Mirghani¹, Osama Hamdi Asiri², Khaled Abdulrahman Alshehri², Maitha MohammedAlthawy³, Amnah Ali Alharbi⁴, Maryam Mohammed Abdulaal⁴, Munia Ghassan Alqahtany⁵, WahbiIbrahim Alnazawi⁶, Dhuha Abduallah Alhuthaily⁷, Raghad Shami Alsharidi⁸, Shroog Ibrahim AlQurashi⁹, Abdulaziz Jameel AlOtaibi¹⁰, Abdulmajeed Albalawi¹¹
DOI:https://doi.org/10.64039/djms.2025.2101 Pages:1-16Background: Restless Legs Syndrome (RLS) is a common but underdiagnosed neurological disorder that negatively affects sleep quality, mood, cardiovascular health, and quality of life. Aim: This systematic review and meta-analysis aimed to estimate the pooled prevalence of RLS among adults in Saudi Arabia and explore variation across population subgroups.
Methods: A comprehensive search was conducted across PubMed, Scopus, Web of Science, and Ovid databases up to October 2025. Observational studies that reported RLS prevalence among adults (≥ 16 years) were considered. The pooled prevalence was calculated using a random-effects model (DerSimonian–Laird method), with heterogeneity assessed by the I² statistic and subgroup analyses conducted by population type and diagnostic criteria.
Results: Twenty studies with a total of 22,383 participants were included.The pooled prevalence of RLS in the general adult population of Saudi Arabia was 12.13% (95% CI, 8.13-16.79%) with high heterogeneity (I² = 98.3%). Subgroup analyses revealed markedly higher prevalence rates in specific clinical groups: 26% among patients with chronic conditions, 26% in pregnant women, and 18% among students. Studies using the International RLS Study Group criteria reported a pooled prevalence of 22%. Heterogeneity persisted within subgroups.
Conclusion: RLS is relatively common among adults in Saudi Arabia, particularly among highrisk and pregnant populations. These findings highlight the need for increased awareness, standardized screening, and further research to improve diagnosis and management of RLS across the Kingdom.
Idiopathic Rapidly Deteriorating Hemophagocytic Lymphohistiocytosis (HLH) Presenting as Fulminant Hepatic Failure in a Young Adult: A Diagnostic Challenge.
Abdulmajeed Albalawi¹*, Wahbi Ibrahim Alnazawi², Maitha Althawy³, Reham Alzahrani⁴, Amnah Alharbi⁵, Sarah Abdullah Alharby⁶, Rimas Alqarni⁷, Hala Alhussein⁸, Hasna Albalawi⁹
DOI:https://doi.org/10.64039/djms.2025.1101 Pages:1-8Background: Hemophagocytic lymphohistiocytosis (HLH) is a rare, life-threatening hyperinflammatory syndrome resulting from uncontrolled activation of cytotoxic T cells and macrophages. It often mimics sepsis, severe viral infections, or autoimmune hepatitis, leading to delayed diagnosis. While primary HLH arises from genetic defects in cytotoxic function and typically manifests in childhood, most adult cases are secondary, triggered by infection, malignancy, or autoimmune disease. Acute liver failure (ALF) as the predominant presentation of HLH is rare and diagnostically challenging, particularly when no clear trigger is identified.
Case summary: We describe a 24-year-old previously healthy Saudi woman with no significant past medical history, who presented with a monthlong history of fever, jaundice, dark urine, and right upper quadrant abdominal pain. Laboratory evaluation revealed acute fulminant liver failure with coagulopathy, bicytopenia (Hb 9.0 g/dL, platelets 54 × 10⁹/L), and extreme hyperferritinemia (>33,511 µg/L).Despite extensive evaluation, infectious, autoimmune, and metabolic causes were excluded. Her neurological status deteriorated, with EEG showing subclinical status epilepticus, requiring ICU admission and intubation. The H-Score was 259, indicating >99% probability of HLH, and bone marrow biopsy confirmed hemophagocytosis. She was treated with Emapalumab (anti–IFN-γ), intravenous immunoglobulin, and corticosteroids. Despite therapy, her condition progressed to multiorgan failure, and she died after 22 days of admission.
Conclusion: This case illustrates an unusual presentation of secondary HLH manifesting as acute liver failure, without an identifiable trigger. We highlight the importance of early consideration of HLH in adults with unexplained ALF and hyperferritinemia, as delayed diagnosis may preclude life-saving immunotherapy.